Reanalysis of Popular Antidepressant Trial Uncovers Reporting Flaws
- A reanalysis of a study found that fluoxetine alone showed no measurable benefit over placebo in treating adolescent depression after 12 weeks
- Researchers uncovered 11 additional suicide-related events that were hidden or misclassified, bringing the total to 21 serious incidents
- Statistical tactics and selective reporting made fluoxetine appear safer and more effective than it really was in clinical trials
- A different reanalysis mentioned that adverse events and many side effects were minimized or excluded from the original reports
- Improving gut health, getting regular exercise, undergoing therapy, and optimizing vitamin D are viable approaches for treating depression
You May Also Like

The Real Truth About Health Free 17 Day Live Online Conference Podcast
Lloyd Burrell, Keith Block M.D., Jeffrey Smith, Michael Klaper M.D., Ralph Moss, Brenda Davis R.D., Mark Sloan, Gerald Posner, Ian Harris M.D., Neil Barnard M.D., Will Tuttle Ph.D., John McDougall M.D., Pam Popper Ph.D., Gabriel Cousens M.D., Brian Clement Ph.D., Anna Maria Clement Ph.D., Marianne W

Guided Meditation
Guided Meditation

Fitness Confidential
Vinnie Tortorich

In Your Right Mind with Monique Rhodes
Monique Rhodes

The Chalene Show | Diet, Fitness & Life Balance
Chalene Johnson

Metabolic Freedom With Ben Azadi
Ben Azadi

The Ultimate Intimacy Podcast
Nick and Amy with The Ultimate Intimacy App

Boundless Body Radio
Casey Ruff

Cat 81 Radio
Cat 81 Radio

Por el Placer de Vivir con el Dr. Cesar Lozano
Uforia Podcasts
Community discussion